Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.
Menéndez-Arias, Luis · Reviews in medical virology · 2011 · DOI
Quick Summary
Researchers discovered a virus called XMRV in some people with prostate cancer and ME/CFS, which generated significant interest. However, other studies have not been able to confirm this finding, leaving uncertainty about whether XMRV actually causes disease in humans. This review examines what we know and don't know about XMRV's role in these conditions.
Why It Matters
XMRV was proposed as a potential infectious cause of ME/CFS, offering a biological explanation for the condition that could have implications for treatment and transmission prevention. Understanding whether this viral association is real or spurious remains important for clarifying ME/CFS etiology and preventing unnecessary public health measures based on unconfirmed claims.
Observed Findings
XMRV discovered in prostate cancer tissues and blood of some ME/CFS patients, but findings not confirmed in other studies
XMRV shows integration site preference for regulatory regions of transcriptionally active genes
Genes related to carcinogenesis and androgen signalling identified near XMRV integration sites
Currently approved antiretroviral drugs (zidovudine, tenofovir, raltegravir) inhibit XMRV replication in vitro
Human restriction factors APOBEC3 and tetherin inhibit XMRV replication
Inferred Conclusions
The relevance and significance of XMRV to human disease remains unclear due to lack of confirmatory evidence
Evidence supporting XMRV involvement in ME/CFS is weak and requires further confirmation and validation
If XMRV is genuine, existing antiretroviral drugs represent potential treatment options
XMRV poses potential public health concerns for blood transfusion screening, gene therapy, and xenotransplantation
Remaining Questions
Why have subsequent studies failed to confirm the initial XMRV findings in ME/CFS?
What is the true prevalence of XMRV in both ME/CFS patients and healthy control populations?
What This Study Does Not Prove
This review does not establish that XMRV causes ME/CFS—it explicitly states that evidence for this association is weak and unconfirmed. The paper does not provide new primary data proving XMRV prevalence in ME/CFS populations or demonstrating causality rather than incidental detection. A review of conflicting evidence cannot resolve whether initial positive findings were genuine discoveries or artifacts.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →